CELMoDs – A Promising Replacement for REVLIMID?

toegevoegd een audio Health

2024-09-26 12:10:04 -

As cancer treatment continues to evolve, finding new therapies is critical for improving patient outcomes. REVLIMID (lenalidomide) has been a key player in treating multiple myeloma, a complex form of blood cancer. However, as patients build resistance to this drug, the need for advanced treatments has become more pressing. This is where CELMoDs—Cereblon E3 Ligase...

0 Reacties 0 aandelen 491 Views 0 voorbeeld